SCHEMBL3213099

SCHEMBL3213099

CC[n+]1ccc(-c2cc[n+](C)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A2 O15244 1/20 0.54
SLC22A1 O15245 1/20 0.54
SLC22A3 O75751 1/20 0.54
SLC6A4 P31645 1/20 0.54
PABPC1 P11940 1/20 0.48
APOBEC3A P31941 1/20 0.48
EIF4H Q15056 1/20 0.48
APOBEC3G Q9HC16 1/20 0.48
MEN1 O00255 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 1/20 0.45
NPC1 O15118 1/20 0.45
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1305882 0.89 MEN1 (0.54) SLC22A2SLC22A1SLC22A3SLC6A4APOBEC3A
SCHEMBL3212692 0.83 MEN1 (0.56) SLC22A2SLC22A1SLC22A3SLC6A4PABPC1
SCHEMBL13910968 0.82 SLC22A2 (0.56) SLC22A2SLC22A1SLC22A3SLC6A4PABPC1
SCHEMBL13587654 0.81 HDAC8 (0.37) SLC22A2SLC22A1SLC22A3SLC6A4PABPC1
Paraquat SCHEMBL4895671 0.81 SLC6A4 (0.77) SLC22A2SLC22A1SLC22A3SLC6A4PABPC1
Paraquat SCHEMBL21652 0.81 SLC6A4 (0.77) SLC22A2SLC22A1SLC22A3SLC6A4PABPC1
SCHEMBL3204759 0.80 MEN1 (0.58) SLC6A4MEN1TP53CYP1A2CYP2D6
SCHEMBL5365467 0.80 MEN1 (0.58) SLC22A2SLC22A1SLC22A3SLC6A4PABPC1
SCHEMBL16843094 0.80 SLC22A2 (0.54) SLC22A2SLC22A1SLC22A3SLC6A4PABPC1
SCHEMBL7968644 0.80 SLC22A2 (0.54) SLC22A2SLC22A1SLC22A3SLC6A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119585421-A Enzyme electrode, enzyme reaction device, enzyme reaction method, modified protein, and method for producing modified protein 松下知识产权经营株式会社 2025-03-07 CN disclosed
CN-119585422-A Enzyme electrode, reduction device, reduction method, modified protein, and method for producing modified protein 松下知识产权经营株式会社 2025-03-07 CN disclosed
US-20230253563-A1 ELECTROACTIVE MATERIALS FOR SECONDARY BATTERIES UCHICAGO ARGONNE, LLC (US) 2023-08-10 US disclosed
CN-115916798-A Method and apparatus for cleaving disulfide bond in protein 松下知识产权经营株式会社 2023-04-04 CN disclosed
CN-115768865-A Allergen inactivation method and allergen inactivation device 松下知识产权经营株式会社 2023-03-07 CN disclosed
CN-115702344-A Target molecule redox method and target molecule redox device 松下知识产权经营株式会社 2023-02-14 CN disclosed
US-9994766-B2 Photoluminescent compounds NORTHWESTERN UNIVERSITY (US) 2018-06-12 US disclosed
US-9803136-B2 Liquid electrolyte-free, solid-state solar cells with inorganic hole transport materials NORTHWESTERN UNIVERSITY (US) 2017-10-31 US disclosed
EP-2067770-B1 PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER WAKO PURE CHEM IND LTD (JP) 2017-04-12 EP disclosed
EP-2602856-B1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME WAKO PURE CHEM IND LTD (JP) 2017-02-22 EP disclosed
EP-2602856-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME Wako Pure Chemical Industries, Ltd. (JP) 2013-06-12 EP disclosed
US-20130143129-A1 NONAQUEOUS ELECTROLYTE SOLUTION, METHOD FOR PRODUCING SAME, AND NONAQUEOUS ELECTROLYTE BATTERY USING THE ELECTROLYTE SOLUTION WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2013-06-06 US disclosed
US-20130130128-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2013-05-23 US disclosed
US-20130063802-A1 VARIABLE TRANSMISSION WINDOW DONNELLY CORPORATION (US) 2013-03-14 US disclosed
US-8269038-B2 Process for production of sulfonic acid ester WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-09-18 US disclosed
US-20110149366-A1 ELECTROCHROMIC DEVICES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-23 US disclosed
US-20100041916-A1 PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-02-18 US disclosed
US-7589883-B2 Vehicular exterior mirror DONNELLY CORPORATION (US) 2009-09-15 US disclosed
EP-2067770-A1 PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER Wako Pure Chemical Industries, Ltd. (JP) 2009-06-10 EP disclosed
US-20080094685-A1 VEHICULAR EXTERIOR MIRROR DONNELLY CORPORATION (US) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041916-A1 PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER SULT1A1, SULT2A1, STS SLC22A2 1351/4885SLC22A1 983/4885SLC22A3 1000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.